Mücahit EMET
(Atatürk Üniversitesi, Tıp Fakültesi, Acil Tıp Anabilim Dalı, Erzurum, Türkiye)
Mustafa UZKESER
(Atatürk Üniversitesi, Tıp Fakültesi, Acil Tıp Anabilim Dalı, Erzurum, Türkiye)
Sibel GÜÇLÜ
(Atatürk Üniversitesi, Tıp Fakültesi, Acil Tıp Anabilim Dalı, Erzurum, Türkiye)
MEHMET ERGİN
(Necmettin Erbakan Üniversitesi Meram Tıp Fakültesi, Acil Tıp Anabilim Dalı, Konya, Türkiye)
ŞAHİN ASLAN
(Atatürk Üniversitesi, Tıp Fakültesi, Acil Tıp Anabilim Dalı, Erzurum, Türkiye)
Yıl: 2016Cilt: 15Sayı: 1ISSN: 2149-5807 / 2149-6048Sayfa Aralığı: 48 - 53İngilizce

141 7
Sleep Disorders in Shift Workers in the Emergency Department and Efficacy of Melatonin
Fen > Tıp > Acil Tıp
DergiDerlemeErişime Açık
  • Kulaksız Y. Çalışma Sürelerinin İş Kazaları Ve Meslek Hastalıkları Üzerine Etkileri. İş Müfettişi Yardımcılığı Etüdü. Erzurum: T.C. Çalışma Ve Sosyal Güvenlik Bakanlığı İş Teftiş Kurulu Başkanlığı, 2011.
  • Alterman T, Luckhaupt SE, Dahlhamer JM, Ward BW, Calvert GM. Preva- lence rates of work organization characteristics among workers in the U.S.: data from the 2010 National Health Interview Survey. Am J Ind Med 2013; 56: 647-59. [CrossRef]
  • Akerstedt T, Ingre M, Broman JE, Kecklund G. Disturbed sleep in shift workers, day workers, and insomniacs. Chronobiol Int 2008; 25: 333-48. [CrossRef]
  • Kohyama J. The possible long-term effects of early-life circadian rhythm disturbance on social behavior. Expert Rev Neurother 2014; 14: 745-55. [CrossRef]
  • Greer SM, Goldstein AN, Walker MP. The impact of sleep deprivation on food desire in the human brain. Nat Commun 2013; 4: 2259. [CrossRef]
  • Gunnell D, Chang SS, Tsai MK, Tsao CK, Wen CP. Sleep and suicide: an analysis of a cohort of 394,000 Taiwanese adults. Soc Psychiatry Psychiatr Epidemiol 2013; 48: 1457-65. [CrossRef]
  • Bliwise DL, Ansari FP. Insomnia associated with valerian and melatonin usage in the 2002 National Health Interview Survey. Sleep 2007; 30: 881-4.
  • Lentino CV, Purvis DL, Murphy KJ, Deuster PA. Sleep as a component of the performance triad: the importance of sleep in a military population. US Army Med Dep J 2013: 98-108.
  • Schernhammer ES, Laden F, Speizer FE, Willett WC, Hunter DJ, Kawachi I, et al. Night-shift work and risk of colorectal cancer in the nurses' health study. J Natl Cancer Inst 2003; 95: 825-8. [CrossRef]
  • Hardeland R, Madrid JA, Tan DX, Reiter RJ. Melatonin, the circadian mul- tioscillator system and health: the need for detailed analyses of periph- eral melatonin signaling. J Pineal Res 2012; 52: 139-66. [CrossRef]
  • De Bacquer D, Van Risseghem M, Clays E, Kittel F, De Backer G, Braeckman L. Rotating shft work and the metabolic syndrome: a prospective study. Int J Epidem 2009; 38: 848-54. [CrossRef]
  • Brown DL, Feskanich D, Sanchez BN, Rexrode KM, Schernhammer ES, Lis- abeth LD. Rotating night shift work and ischemic stroke. Am J Epidemiol 2009; 169: 1370-7. [CrossRef]
  • Fujino Y, Iso H, Tamakoshi A, Inaba Y, Koizumi A, Kubo T, et al. A prospec- tive cohort study of shift work and risk of ischemic heart disease in Japa- nese male workers. Am J Epidemiol 2006; 164: 128-35. [CrossRef]
  • Lieu SJ, Curhan GC, Schernhammer ES, Forman JP. Rotating night shift work and disperate hypertension risk in African-Americans. J Hypertens 2012; 30: 61-6. [CrossRef]
  • Lund J, Arendt J, Hampton SM, English J, Morgan LM. Postprandial hor- mone and metabolic responses among shift workers in Antarctica. J En- docrinol 2001; 171: 557-64. [CrossRef]
  • Pan A, Schernhammer ES, Sun Q, Hu FB. Rotating night shift work and risk of type 2 diabetes: two perspective cohort studies in women. PLoS Med 2011; 8: e1001141.
  • McDonald AD, McDonald JC, Armstrong B, Cherry NM, Cote R, Lavole J, et al. Fetal death and work in pregnancy. Br J Ind Med 1988; 45: 148-57. [CrossRef]
  • Marino JL, Holt VL, Chen C, Davis S. Shif work, hCLOCK T3111C polymor- phism, and endometriosis risk. Epidemiology 2008; 19: 477-84. [CrossRef]
  • Straif K, Baan R, Grosse Y, Secretan B, El Ghissassi F, Bouvard V, et al. Car- cinogenicity of shift work, painting, and fire-fighting. Lancet Oncol 2007; 8: 1065-6. [CrossRef]
  • Viswanathan AN, Hankinson SE, Schernhammer ES. Night shift work and the risk of endometrial cancer. Cancer Res 2007; 67: 10618-22. [CrossRef]
  • Kubo T, Ozasa K, Mikami K, Wakai K, Fujino Y, Watanabe Y, et al. Prospec- tive cohort study of the risk of prostate cancer among rotating-shift workers: finding from Japan collaborative cohort study. Am J Epidemiol 2006; 164: 549-55. [CrossRef]
  • Hansen J. Increased breast cancer risk among women who work pre- dominantly at night. Epidemiology 2001; 12: 74-7. [CrossRef]
  • Rosenthal NE, Genhart M, Jacobsen FM, Skwerer RG, Wehr TA. Distur- bances of appetite and weight regulation in seasonal affective disorder. Ann N Y Acad Sci 1987; 499: 216-30. [CrossRef]
  • Wittmann M, Dinich J, Merrow M, Roenneberg T. Social jetlag: misalign- ment of biological and social time. Chronobiol Int 2006; 23: 497-509. [CrossRef]
  • Randler C, Vollmer C. Aggression in young adults--a matter of short sleep and social jetlag? Psychol Rep 2013; 113: 754-65.
  • Pandi-Perumal SR, Trakht I, Srinivasan V, Spence DW, Maestroni GJ, Zis- apel N, et al. Physiological effects of melatonin: role of melatonin recep- tors and signal transduction pathways. Prog Neurobiol 2008; 85: 335-53. [CrossRef]
  • Hardeland R. Melatonin in aging and disease -multiple consequences of reduced secretion, options and limits of treatment. Aging Dis 2012; 3: 194-225.
  • Comai S, Gobbi G. Unveiling the role of melatonin MT2 receptors in sleep, anxiety and other neuropsychiatric diseases: a novel target in psy- chopharmacology. J Psychiatry Neurosci 2014; 39: 6-21. [CrossRef]
  • Gershell L. Insomnia market. Nat Rev Drug Discov 2006; 5: 15-6. [CrossRef]
  • Morin CM, LeBlanc M, Daley M, Gregoire JP, Merette C. Epidemiology of insomnia: prevalence, self-help treatments, consultations, and determi- nants of help-seeking behaviors. Sleep Med 2006; 7: 123-30. [CrossRef]
  • National Institutes of H. National Institutes of Health State of the Science Conference statement on Manifestations and Management of Chronic Insomnia in Adults, June 13-15, 2005. Sleep 2005; 28: 1049-57.
  • Campos Costa I, Nogueira Carvalho H, Fernandes L. Aging, circadian rhythms and depressive disorders: a review. Am J Neurodegener Dis 2013; 2: 228-46.
  • Mendelson WB, Sack DA, James SP, Martin JV, Wagner R, Garnett D, et al. Frequency analysis of the sleep EEG in depression. Psychiatry Res 1987; 21: 89-94. [CrossRef]
  • Germain A, Kupfer DJ. Circadian rhythm disturbances in depression. Hum Psychopharmacol 2008; 23: 571-85. [CrossRef]
  • Perlis ML, Giles DE, Buysse DJ, Tu X, Kupfer DJ. Self-reported sleep distur- bance as a prodromal symptom in recurrent depression. J Affect Disord 1997; 42: 209-12. [CrossRef]
  • Srinivasan V, Pandi-Perumal SR, Trakht I, Spence DW, Hardeland R, Poeg- geler B, et al. Pathophysiology of depression: role of sleep and the mela- tonergic system. Psychiatry Res 2009; 165: 201-14. [CrossRef]
  • Anderson JL, Rosen LN, Mendelson WB, Jacobsen FM, Skwerer RG, Jo- seph-Vanderpool JR, et al. Sleep in fall/winter seasonal affective disorder: effects of light and changing seasons. J Psychosom Res 1994; 38: 323-37. [CrossRef]
  • Beck-Friis J, Kjellman BF, Aperia B, Undén F, von Rosen D, Ljunggren JG, et al. Serum melatonin in relation to clinical variables in patients with major depressive disorder and a hypothesis of a low melatonin syndrome. Acta Psychiatr Scand 1985; 71: 319-30. [CrossRef]
  • Rao AV, Devi SP, Srinivasan V. Urinary melatonin in depression. Indian J Psychiatry 1983; 25: 167-72.
  • Rubin RT, Heist EK, McGeoy SS, Hanada K, Lesser IM. Neuroendocrine aspects of primary endogenous depression. XI. Serum melatonin mea- sures in patients and matched control subjects. Arch Gen Psychiatry 1992; 49: 558-67. [CrossRef]
  • Etain B, Milhiet V, Bellivier F, Leboyer M. Genetics of circadian rhythms and mood spectrum disorders. Eur Neuropsychopharmacol 2011; 21(Suppl 4): S676-82.
  • Castaneda TR, de Prado BM, Prieto D, Mora F. Circadian rhythms of dopa- mine, glutamate and GABA in the striatum and nucleus accumbens of the awake rat: modulation by light. J Pineal Res 2004; 36: 177-85. [CrossRef]
  • Heaton P, Davis RE, Happe FG. Research note: exceptional absolute pitch perception for spoken words in an able adult with autism. Neuropsycho- logia 2008; 46: 2095-8. [CrossRef]
  • Pjrek E, Winkler D, Konstantinidis A, Willeit M, Praschak-Rieder N, Kasper S. Agomelatine in the treatment of seasonal affective disorder. Psycho- pharmacology (Berl) 2007; 190: 575-9. [CrossRef]
  • Sohn CH, Lam RW. Update on the biology of seasonal affective disorder. CNS Spectr 2005; 10: 635-46.
  • Axelsson J, Karadottir R, Karlsson MM. Differences in prevalence of sea- sonal affective disorder that are not explained by either genetic or lati- tude differences. Int J Circumpolar Health 2002; 61: 17-20. [CrossRef]
  • Rosenthal NE, Sack DA, Gillin JC, Lewy AJ, Goodwin FK, Davenport Y, et al. Seasonal affective disorder. A description of the syndrome and pre- liminary findings with light therapy. Arch Gen Psychiatry 1984; 41: 72-80. [CrossRef]
  • Claustrat B, Brun J, Chazot G. The basic physiology and pathophysiology of melatonin. Sleep Med Rev 2005; 9: 11-24. [CrossRef]
  • Genell H. Melatonin and the pineal gland. J Neurosci Nurs 2002; 34: 74-8. [CrossRef]
  • Uz T, Arslan AD, Kurtuncu M, Imbesi M, Akhisaroglu M, Dwivedi Y, et al. The regional and cellular expression profile of the melatonin receptor MT1 in the central dopaminergic system. Brain Res Mol Brain Res 2005; 136: 45-53. [CrossRef]
  • Pandi-Perumal SR, Srinivasan V, Poeggeler B, Hardeland R, Cardinali DP. Drug Insight: the use of melatonergic agonists for the treatment of insom- nia-focus on ramelteon. Nat Clin Pract Neurol 2007; 3: 221-8. [CrossRef]
  • Hardeland R, Poeggeler B, Srinivasan V, Trakht I, Pandi-Perumal SR, Car- dinali DP. Melatonergic drugs in clinical practice. Arzneimittelforschung 2008; 58: 1-10.
  • Agomelatine: new drug. Adverse effects and no proven efficacy. Prescri- re Int 2009; 18: 241-5.
  • Costello RB, Lentino CV, Boyd CC, O'Connell ML, Crawford CC, Sprengel ML, et al. The effectiveness of melatonin for promoting healthy sleep: a rapid evidence assessment of the literature. Nutr J 2014; 13: 106. [CrossRef]
  • Walker MP, Stickgold R. Sleep-dependent learning and memory consoli- dation. Neuron 2004; 44: 121-33. [CrossRef]
  • Thase ME. Depression, sleep, and antidepressants. J Clin Psychiatry 1998; 59(Suppl 4): 55-65.
  • Deboer T, Vansteensel MJ, Detari L, Meijer JH. Sleep states alter activity of suprachiasmatic nucleus neurons. Nat Neurosci 2003; 6: 1086-90. [CrossRef]
  • Lam RW. Sleep disturbances and depression: a challenge for antidepres- sants. Int Clin Psychopharmacol 2006; 21(Suppl 1): S25-9.
  • Armitage R, Hoffmann R, Fitch T, Trivedi M, Rush AJ. Temporal character- istics of delta activity during NREM sleep in depressed outpatients and healthy adults: group and sex effects. Sleep 2000; 23: 607-17.
  • Imbesi M, Uz T, Yildiz S, Arslan AD, Manev H. Drug- and region-specific ef- fects of protracted antidepressant and cocaine treatment on the content of melatonin MT(1) and MT(2) receptor mRNA in the mouse brain. Int J Neuroprot Neuroregener 2006; 2: 185-9.
  • Loo H, Hale A, D'Haenen H. Determination of the dose of agomelatine, a melatoninergic agonist and selective 5-HT(2C) antagonist, in the treat- ment of major depressive disorder: a placebo-controlled dose range study. Int Clin Psychopharmacol 2002; 17: 239-47. [CrossRef]
  • Rouillon F. Efficacy and tolerance profile of agomelatine and practical use in depressed patients. Int Clin Psychopharmacol 2006; 21(Suppl 1): S31-5.
  • Krauchi K, Cajochen C, Wirz-Justice A. A relationship between heat loss and sleepiness: effects of postural change and melatonin administration. J Appl Physiol (1985) 1997; 83: 134-9.
  • van den Heuvel CJ, Kennaway DJ, Dawson D. Thermoregulatory and sop- orific effects of very low dose melatonin injection. Am J Physiol 1999; 276: E249-54.
  • Liira J, Verbeek J, Ruotsalainen J. Pharmacological interventions for sleepiness and sleep disturbances caused by shift work. JAMA 2015; 313: 961-2. [CrossRef]
  • Liira J, Verbeek JH, Costa G, Driscoll TR, Sallinen M, Isotalo LK, et al. Phar- macological interventions for sleepiness and sleep disturbances caused by shift work. Cochrane Database Syst Rev 2014; 8: CD009776.
  • Claustrat B, Brun J, David M, Sassolas G, Chazot G. Melatonin and jet lag: confirmatory result using a simplified protocol. Biol Psychiatry 1992; 32: 705-11. [CrossRef]
  • Morgenthaler TI, Lee-Chiong T, Alessi C, Friedman L, Aurora RN, Boe- hlecke B, et al. Practice parameters for the clinical evaluation and treat- ment of circadian rhythm sleep disorders. An American Academy of Sleep Medicine report. Sleep 2007; 30: 1445-59.
  • Dowling GA, Burr RL, Van Someren EJ, Hubbard EM, Luxenberg JS, Mas- tick J, et al. Melatonin and bright-light treatment for rest-activity disrup- tion in institutionalized patients with Alzheimer's disease. J Am Geriatr Soc 2008; 56: 239-46. [CrossRef]

TÜBİTAK ULAKBİM Ulusal Akademik Ağ ve Bilgi Merkezi Cahit Arf Bilgi Merkezi © 2019 Tüm Hakları Saklıdır.